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Frances Connan5, Ken Goss6, Bert Laszlo7, John Morgan8, Kim Moore9, David Robertson10, Saeidi S8,
Christa Schreiber-Kounine11, Sonu Sharma12, Linette Whitehead4, Ulrike Schmidt1 and Janet Treasure1Background: Individual, family and service level characteristics and outcomes are described for adult and
adolescent patients receiving specialist inpatient or day patient treatment for anorexia nervosa (AN). Potential
predictors of treatment outcome are explored.
Method: Admission and discharge data were collected from patients admitted at 14 UK hospital treatment units
for AN over a period of three years (adult units N = 12; adolescent N = 2) (patients N = 177).
Results: One hundred and seventy-seven patients with a severe and enduring illness with wide functional
impairment took part in the study. Following inpatient care, physical improvement was moderate/good with a large
increase in BMI, although most patients continued to have a clinical level of eating disorder symptoms at discharge.
The potentially modifiable predictors of outcome included confidence to change, social functioning and carer
expressed emotion and control.
Conclusions: Overall, the response to inpatient treatment was modest particularly in the group with a severe
enduring form of illness. Adolescents had a better response. Although inpatient treatment produces an
improvement in physical health there was less improvement in other eating disorder and mood symptoms. As
predicted by the carer interpersonal maintenance model, carer behaviour may influence the response to inpatient
care, as may improved social functioning and confidence to change.
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There is a large amount of uncertainty about the manage-
ment of patients with severe, persisting eating disorders
(EDs) [1,2]. In part, this is reflected in the cultural and
temporal changes in the use of inpatient treatment and
the variation in service level treatment parameters in Eur-
ope [3] and in the USA and Canada [4]. More recently,
day patient services (typically a 9–5pm programme, 5 days
a week with 2 or 3 meals) are being offered as an alterna-
tive to inpatient care (residential, 7 days a week with all
meals), including in the UK [5] for those not at high med-
ical risk [6-10]. A recent meta-analysis, which examined* Correspondence: elizabeth.goddard@kcl.ac.uk
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reproduction in any medium, provided the orfactors that predicted weight gain in anorexia nervosa
(AN), concluded that inpatient care was associated with
the fastest change [11]. An additional goal of inpatient
care is to facilitate a move towards recovery and a better
quality of life. Therefore broader factors, other than weight
gain alone, have to be considered.
In the UK the National Institute of Clinical Excellence
(NICE) published guidelines for the treatment of AN and
recommend inpatient treatment for those with high med-
ical and/or psychosocial risk and who have failed to re-
spond to less intensive treatments [12]. In line with these
guidelines, current cohorts are older and have a more se-
vere and enduring illness [13,14] than in previous UK in-
patient cohorts from 1959–64 [15] and 1979–84 [16].
Studies describing the clinical status and treatment re-
sponse of patients admitted for hospital care in the UK areal Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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not capture variation in case mix across sites. Other coun-
tries have different service models of care than those out-
lined in the NICE guidelines, but there is a lack of
evidence upon which to base the models of care provision.
The restoration of nutritional health in patients with
this degree of severe weight loss takes time and this ex-
plains why, compared to other psychiatric disorders, AN
has the highest proportion of admissions in the UK with
an average length of stay over 90 days (26.8%) and the
longest median length of stay (36 days) [17]. This con-
tributes to the high cost of illness [18,19]. Furthermore,
poor treatment adherence (drop out or failure to meet
treatment goals) is a feature of inpatient care [20,21].
Identifying factors that can be targeted to increase the
cost-effectiveness and acceptability of inpatient care has
implications for the individual, their family and service
providers. The main factors that predict outcome from
inpatient care are fixed and include the severity (e.g.
BMI) and duration of illness [5,22]. However, both intra-
and inter-personal psychosocial factors can be modified
and may influence the response to treatment. For ex-
ample, individual factors such as motivation to change
have been associated with reduced rates of relapse post-
inpatient care and may be important for engendering
change within the hospital setting [23].
Interpersonal factors form a key component of a the-
oretical model designed to explain treatment resistance
in AN [24]. For example. in response to the manifesta-
tions of AN in the patient, carers exhibit measurable
anxiety and depression and it is hypothesised that these
symptoms directly and indirectly affect the individual
with AN, [24,25]. Moreover, eating symptoms and dis-
tress have been shown to be associated with carer dis-
tress, expressed emotion, and psychological control in a
model developed using cross sectional data [26]. It is
therefore of interest to examine whether these factors
have an impact on response to inpatient treatment.
The present study
The first aim of this paper is to describe the clinical fea-
tures of patients admitted to a cross section of UK services
for inpatient and day patient care on admission and at dis-
charge. A second aim is to examine whether intra- (ED
symptoms, mood, and motivation to change) and interper-
sonal factors (perceived expressed emotion, control, qual-
ity of social relationships) contribute to the response to
inpatient care in terms of ED psychopathology. It is our
expectation that ED symptoms, low mood and low motiv-
ation to change will contribute to a more negative re-
sponse to inpatient care. Similarly, it is our expectation
that high perceived carer expressed emotion and control
and low quality of social relationships will contribute
negatively to the response to inpatient care.Method
Participants
Participants were recruited from a consecutive series of
inpatients and day patients admitted to specialist ED
hospital services in the UK over a three year period
(September 2008 and August 2011). Day patients in this
context were patients who required non-residential
intensive specialist treatment (≥ 4 days a week). The
families of these patients agreed to participate in a ran-
domised controlled trial (RCT) to examine the impact of
a guided self-help skills training intervention on the out-
comes of carers and the individual with AN post dis-
charge from hospital treatment. However, only patient
data are included in this paper. Trial protocol and
recruitment procedure are described in more detail in
another paper [27]. The inclusion criteria required indi-
viduals to be fluent in English, have a primary diagnosis
of AN or Eating Disorder Not Otherwise Specified with
Anorexic symptoms (diagnosed using clinical interview
ICD 10 criteria), and have at least one carer consent to
participate in the project. Some hospitals used a step
down procedure whereby patients may be gradually
moved to a less intensive form of treatment (i.e. from in-
patient to day patient) prior to discharge into outpatient
services or the community. Patients were considered dis-
charged when they ceased to receive intensive treatment
for their ED (that is, inpatient treatment or day patient
treatment ≥ 4 days a week). Those who were transferred
to residential care or day care ≥ 4 days a week where
they continued to receive specialist and intensive ED
treatment were not considered to be discharged; how-
ever, those who moved on to more generic supported
housing services where they did not receive specialist
intensive support were. Patients had to maintain their
“discharged” status for a minimum of four weeks to be
counted as formally discharged. If they returned to hos-
pital within four weeks, this period was considered part
of a continuous hospital admission. Details on whether
patients completed the treatment programme or dis-
charged themselves without recommendation by the
treatment centre were not available for all sites and are
therefore not included.
Participating centres
Data from participants of 14 hospitals were included in
this paper. Twelve hospitals are adult ED specialist in-
patient units and two are adolescent hospital units (one
specialist ED and one general psychiatric with ED beds).
Four sites recruited inpatients as well as day patients
into the study. We wanted to have an ecologically rele-
vant sample representative of current UK practice. Each
service followed a different ethos with different practices
relating to the transition back to the community. Since
the numbers are small, data collected from day patients
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hospitals are NHS operated except one which is private
and accepts NHS referrals. More details can be found in
a previous paper [27].
Ethics and governance
Ethics approval was granted by the Royal Free Hospital
Ethics Committee (08/H0720/41) and site-specific ethics
and governance approval was granted on all participat-
ing sites. This study was adopted by the Mental Health
Research Network (MHRN) and Clinical Studies Officers
supported the study.
Assessment measures
Patients were assessed at admission and after discharge
from hospital. Patients completed the first assessment
on admission to hospital after providing consent for the
study. Patients were not re-contacted by the study team
until time of discharge. The hospital notified the treat-
ment team that the patient had been discharged and
questionnaires were subsequently sent to the patient at
their home.
Primary outcomes
Body Mass Index (BMI): BMI (weight/height2) was ob-
tained from the medical notes for each patient at admis-
sion and at discharge. This was available for all patients
at admission. It was necessary to use self-reported
weight for N = 14 patients (8%) at discharge.
Eating Disorder Examination – Questionnaire (EDEQ):
A self-report measure assessing ED symptoms over the
previous 28 days [28]. This instrument has good reliabil-
ity and validity in ED samples [29]. High scores indicate
greater ED psychopathology.
Depression, Anxiety and Stress Scale (DASS): A 21-
item self-report measure to assess mood state over the
past seven days using a 4-point Likert scale [30]. Total
score as a measure of general distress or depression,
anxiety and stress subscales can be used. High scores in-
dicate higher symptomatology. This measure has good
reliability and validity [30,31].
Motivation to change: Patients are asked to rate, on
Likert scales measuring 1 (not at all) to 10 (very), their im-
portance and confidence in changing their ED behaviours.
World Health Organization – Quality of Life Ques-
tionnaire (brief version) (WHOQOL): Items are rated on
a 5-point Likert scale pooled in four domains: physical
health, psychological, social relationships and environ-
ment. Two single items evaluate the ‘Overall Quality of
Life’ and ‘General Health’ facet. Good psychometric data
have been reported for this scale [32]. High scores indi-
cate better quality of life.
Levels of Expressed Emotion Scale (LEE): This is a 60-
item self-report scale for patients to report on the presenceof items representing high or low levels of expressed emo-
tion in their carer using a true/false dichotomy. A total
score as well as subscales can be derived [33,34].
Psychological Control Scale (Youth self-report; PCS):
This 8-item questionnaire assesses the level of perceived
psychological control displayed by carers (reported for
mother and father separately) [35].
Statistical analyses
All statistics were carried out using SPSS version 20.0.
Three participants (2 adult inpatients, 1 adolescent in-
patient) were censored due to extremely long hospital
admissions (duration stay > 132.5 weeks at time of writ-
ing). These patients remained in hospital at the time of
data analysis and analyses were conducted without their
discharge data.
Sample description and treatment outcomes
Data were split according to service characteristics (adult
vs. adolescent, inpatient vs. day patient) to provide a com-
prehensive description of the sample characteristics.
Paired t-tests and McNemar tests were used to examine
change over the treatment period within each group. Dir-
ect comparisons of change in symptomatology between
adult inpatients, adolescent inpatients, and day patients
were not made because of the large variation in sample
size. Instead, effect sizes are presented for a descriptive
comparison of the size of change between groups. Hoch-
berg’s improved Bonferroni correction was used to adjust
for multiple testing. Cohen’s d effect sizes are presented
for continuous data to enable comparison across sites. Ef-
fect sizes are computed using output from paired t-tests
and therefore do not consider non-responders.
Predictors of outcome
Data on one or more key variables were missing from
N=71 patients and these were excluded from the modeling
of predictors which therefore included 107 participants.
The data were explored for fit with the assumptions
required for a multivariate analysis. Appropriate trans-
formations were applied to produce variables which
were normally distributed. Descriptive statistics (mean,
standard deviations, skewness and kurtosis) and Pearson
correlation analyses between variables were examined.
To examine the degree to which individual and interper-
sonal variables are linked to ED symptoms at discharge,
a two-step sequence of hierarchical regression analyses
with the EDEQ at discharge as the criterion variable
were conducted. All individual variables (BMI on admis-
sion, ED symptoms on admission, patient’s distress and
confidence to change) were entered in the first block. All
interpersonal variables (LEE, social quality of life and
perceived psychological control) were entered in the sec-
ond block.
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Engagement into the study procedure
The consort diagram of the patient and carer flow into
the initial phase of the study is shown in Figure 1. In
total, 30% of patients who were approached took part in
the study. Reasons for not consenting into the study var-
ied but the most common reasons were that patients
were discharged prior to consent, didn’t have time to
take part in research, or lacked a carer. Also, patients
were excluded because their carers did not consent to
take part in the study.
Clinical and demographic data
Clinical characteristics of patients at admission
Data are presented for inpatients and day patients (adults)
and adolescents (inpatients) separately. The baselineFigure 1 Consort flow diagram.demographic descriptions for the patients are shown in
Table 1. Baseline and discharge clinical data are presented
in Table 2. Please refer to Additional file 1 for admission
characteristics of inpatients, presented by site. Table 3 de-
picts discharge values and effect sizes for inpatients only
by site. There were no significant differences at baseline
between those for whom discharge data was available for
those for whom data was unavailable.
The case mix of adult inpatients
Overall, inpatients in adult units (aged 16–62 years) are
admitted to hospital with very low BMI. Seventy-nine
percent of patients had a BMI ≤ 15. Five patients (3%)
had a BMI above 17.5 and had been admitted to hospital
due to significant and rapid weight loss or extreme
binge-purge symptoms. Both the specific ED and more
Table 1 Demographic characteristics of patients
Adult Inpatients (N=150) Adult Day patients (N=16) Adolescent Inpatients (N=11)
Frequency (%)
Female : Male 95 : 5 100 : 0 91 : 10
Ethnicity
White (British, Irish, Other) 94 69 100
Asian/Asian British/Mixed 6 31 0
Marital Status
Married/Living together/In a relationship 22 19 0
Single 75 75 100
Divorced/Separated/Widowed 3 6 0
Highest Qualifications
None 4 0 30
O-Level/GCSE/A-Level/GNVQ 52 38 60
Diploma/BTEC 10 6 0
University degree or higher 33 56 0
Other 1 0 10
Employment Status
Paid employment (full-time : part-time) 11 : 5 0 : 13 0 : 0
Homemaker/Unemployed/Sick/Retired 56 62 10
Student 27 25 90
Other 1 0 0
Living Situation
Living alone 14 19 0
Living with partner 19 12 0
Living with relatives 54 44 89
Other (e.g. hostel, flat with friends) 13 25 11
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the total range of the scales but the large majority of pa-
tients scored in the severe to extremely severe ranges.
Patients scored moderately high on “importance to
change” but lower on “confidence to change”.
The case mix at admission varied somewhat between
services. BMI on admission was slightly lower at 2 sites
in particular (7, 9) and participants were slightly older in
3 centres (2, 7, 9). This may reflect their roles as national
specialist centres. Patients from almost all centres re-
ported high ED psychopathology and objective bingeing,
purging and excessive exercise. Mean levels of depres-
sion and anxiety were in the severe range for most sites.Adult vs Adolescent Adolescents (aged 13–17 years old)
tended to have a higher BMI at admission (d = −0.6) and
reported lower ‘importance to change’ than adults.Inpatients vs. day patients Day patients had higher
BMI at admission, higher lowest lifetime BMI and fewerprevious admissions than adult inpatients (50% of day
patients compared to 70% of inpatients).Interpersonal factors Perceived expressed emotion
(criticism and overprotection and perceived psychological




There was considerable individual variation in length of
admission (4 – 141.6 weeks). There was large variation in
the mean length of admissions between sites (15.8 – 38.1
weeks) where some sites reported twice the length of ad-
missions than others. Thirteen patients (9%) received a
stepped care treatment package (inpatient for an average
of 24.2 weeks followed by 16.2 weeks day patient care).
Table 2 Patient baseline and discharge clinical characteristics: inpatients split by adult and adolescent site *




















AGE 26.5 (8.9) 15.2 (1.6) 24.7 (5.3)
AGE ONSET 16.8 (5.6) 13.5 (1.4) 16.1 (4.1)
LENGTH ILL (YEARS) 8.2 (8.3) 2.0 (1.7) 7.3 (7.0)
LOWEST BMI 12.6 (1.7) 14.0 (2.0) 14.6 (1.6)
# PREVIOUS ADMISSIONS a 1.0 (0-2.0) 0.4 (0.5) 0 (0-2.0)
Treatment
LoS (weeks) 26.4 (17.9) 29.0 (11.9) 17.8 (10.4)
Weight gain
BMI 14.0 (1.7) 17.3 (2.1) -21.4, p < .001 1.7 15.0 (1.6) 18.5 (1.3) -5.6, p = .001 3.1 17.3 (2.4) 18.5 (2.2) -2.1, p = .059 0.4
Weight (kgs) 38.3 (6.0) 47.1 (7.5) -20.6, p < .001 1.3 40.8 (6.1) 50.9 (5.3) -5.6, p = .003 2.1 45.1 (7.4) 48.4 (6.0) -2.0, p = .065 0.4
Weekly gain (kg) 0.4 (0.3) 0.5 (0.4) 0.1 (0.3)
BMI 6 weeks* 15.1 (1.8) 15.1 (1.1) 17.5 (2.4)
6wk rate of weekly weight * 0.6 (0.5) 0.2 (0.2) -0.2 (0.4)
Eating psychopathology (0-6) and behaviours
EDE-Q Total 4.2 (1.3) 3.3 (1.6) 6.5, p < .001 -0.6 4.1 (1.4) 3.5 (1.0) 0.3, p = .778 -0.2 4.4 (1.0) 3.7 (1.3) 2.7, p = .020 -0.7
EDE-Q Restraint 3.7 (1.8) 2.9 (1.9) 3.7, p < .001 -0.4 3.7 (2.2) 2.7 (1.2) 0.3, p = .802 -0.2 3.6 (2.0) 3.3 (1.4) 1.4, p = .186 -0.2
EDE-Q Eating Concern 3.7 (1.3) 2.8 (1.5) 6.3, p < .001 -0.6 3.6 (1.5) 3.0 (1.5) -0.1, p = .898 -0.1 4.0 (1.1) 3.3 (1.4) 2.3, p = .041 -0.7
EDE-Q Shape Concern 5.0 (1.2) 4.1 (1.8) 5.9, p < .001 -0.5 5.2 (0.8) 4.8 (0.8) 0.8, p = .499 -0.3 5.3 (0.9) 4.5 (1.5) 2.8, p = .016 -0.8
EDE-Q Weight Concern 4.5 (1.4) 3.3 (1.7) 7.2, p < .001 -0.7 4.1 (1.7) 3.7 (1.1) 0.4, p = .729 -0.3 4.7 (1.1) 3.7 (1.4) 2.9, p = .012 -0.8
OBE: Yes 55 (37%) 37 (31%) p = .440 -0.2 3 (38%) 3 (50%) p = 1.0 0.3 7 (44%) 10 (67%) p = .250 0.6
LOC: Yes 82 (59%) 62 (56%) p = .871 -0.1 3 (43%) 2 (40%) p = 1.0 -0.1 12 (75%) 8 (52%) p = .625 -0.6
SIV: Yes 42 (30%) 26 (23%) p = 1.0 -0.2 2 (29%) 1 (20%) p = 1.0 -0.3 6 (38%) 5 (39%) p = 1.0 0.0
LAX: Yes 29 (20%) 12 (11%) p = .152 -0.4 0 1 (20%) p = 1.0 - 3 (19%) 2 (15%) p = 1.0 -0.2
DIUR: Yes 8 (6%) 0 p = .063 - 0 0 - - 1 (6%) 2 (15%) p = 1.0 -0.5
EXC. EX: Yes 83 (58%) 41 (37%) p = .012 -0.5 5 (63%) 1 (20%) p = .500 -1.2 7 (44%) 7 (54%) p = 1.0 0.3
Mood and Quality of life
DASS total 77.8 (27.9) 64.8 (31.7) 4.9, p < .001 -0.4 75.3 (33.4) 36.0 (16.4) 1.5, p = .233 -0.9 79.1 (25.2) 67.5 (33.0) 1.1, p = .277 -0.4
DASS Depression 28.4 (11.3) 24.3 (12.7) 3.8, p < .001 -0.3 30.5 (11.8) 14.0 (8.9) 1.2, p = .309 -0.9 29.5 (10.8) 25.1 (14.7) 1.0, p = .316 -0.4
DASS Anxiety 20.3 (10.6) 15.7 (11.7) 4.5, p < .001 -0.4 15.5 (12.4) 8.4 (5.2) p = .285 -0.4 20.1 (7.6) 18.9 (10.1) -0.4, p = .726 -0.3


















Table 2 Patient baseline and discharge clinical characteristics: inpatients split by adult and adolescent site * (Continued)
WHO QoL (1-5) 2.4 (1.0) 3.2 (0.9) -6.7, p < .001 0.8 2.3 (0.9) 4.0 (1.0) -2.0, p = .141 1.6 2.9 (1.0) 2.8 (1.3) 0.4, p = .721 -0.1
WHO HEALTH (1-5) 2.3 (0.9) 2.9 (1.0) -5.0, p < .001 0.5 3.0 (1.2) 4.2 (0.8) -1.2, p = .308 0.6 2.4 (1.0) 2.3 (1.0) 0.4, p = .721 -0.1
WHO Psychological 26.2 (17.5) 35.5 (19.5) -5.6, p < .001 0.5 26.0 (18.2) 46.7 (20.5) -0.7, p = .519 0.5 22.1 (17.3) 26.3 (20.7) -0.9, p = .378 0.2
WHO Social 40.2 (22.1) 40.8 (21.7) 0.6, p = .581 0.1 38.0 (31.6) 41.7 (25.7) 0.7, p = .537 0.3 33.3 (18.0) 26.3 (17.3) 0.3, p = .764 -0.1
WHO Physical 51.0 (20.0) 62.2 (20.8) -5.3, p < .001 0.5 67.0 (20.4) 86.4 (8.5) -1.6, p = .207 0.3 46.2 (18.1) 45.3 (22.6) 0.7, p = .484 -0.1
WHO Environment 52.7 (16.9) 61.2 (17.0) -5.2, p < .001 0.4 56.6 (14.0) 72.5 (19.8) -1.6, p = .215 0.7 53.6 (9.9)-0.2 50.3 (16.1) 1.1, p = .296
Motivation (1-10)
Importance to change 8.0 (2.3) 7.5 (2.5) 2.6, p = .010 -0.3 6.3 (4.3) 4.2 (3.3) 2.1, p = .127 -0.6 8.9 (1.1) 8.4 (2.5) 0.5, p = .603 -0.2
Confidence to change 5.5 (2.6) 5.4 (2.5) 1.2, p = .222 -0.1 5.0 (2.5) 6.2 (2.3) -0.9, p = .448 0.6 5.0 (2.0) 4.7 (2.6) 0.4, p = .711 -0.3
Perceived support from carers
LEE primary carer 20.0 (15.4) 18.3 (13.8) 1.3, p = .182 -0.1 20.6 (15.0) 14.7 (6.7) 0.2, p = .858 -0.1 19.0 (9.9) 22.5 (12.9) -1.2, p = .249 0.3
PCS Mother 2.4 (1.0) 2.4 (1.0) -0.5, p = .633 0.0 2.0 (0.8) 1.8 (0.1) 0.5, p = .670 -0.04 2.5 (0.9) 2.5 (0.9) -0.1, p = .902 -0.02
PCS Father 2.2 (1.0) 2.1 (0.9) 0.5, p = .618 -0.04 1.9 (0.5) 1.9 (0.3) -0.04, p = .973 0.03 2.4 (1.0) 2.5 (1.3) -0.4, p = .708 -0.1
* Not every participant answered every question; ª Median and IQR reported. b data for one site not presented in isolation as only 2 participants were inpatients; day patients are not included in individual site
calculations; ES: Effect size; SD: Standard Deviation; N = sample number included; BMI: Body Mass Index; EDE-Q Eating Disorder Examination Questionnaire; OBE: Objective binge episodes with loss of control; LOC: Loss
of control other than binge; SIV: Self-induced vomiting; LAX: Laxative use; EXER: Excessive exercise; DASS: Depression, Anxiety and Stress Scale; WHO: World Health Organization; QoL: Overall quality of life (1–5 high);
HEALTH: Overall satisfaction with health (1–5 high); LEE: Levels of Expressed Emotion; PCS: Psychological Control Scale; Analyses for change over treatment period for adolescent and day patient samples were con-



















Table 3 Descriptive data (mean, standard deviation) at discharge and effect sizes for change pre- and post- inpatient treatment by centre: inpatients only a
1 2 3 4 5 6 7 8 9 10 11 12 13* 14*
N = 21 N = 17 N = 16 N = 16 N = 12 N = 15 N = 11 N = 11 N = 7 N = 6 N = 3 N = 2 N = 5 N = 2
Age at admission 27.9 (8.2) 33.1 (14.3) 24.3 (8.2) 24.6 (9.6) 23.7 (5.0) 23.4 (5.3) 23.4 (7.4) 30.8 (6.7) 30.5 (8.0) 21.2 (3.3) 25.0 (9.6) 24.5 (7.8) 15.6 (1.5) 15.3 (0.6)
Admission (weeks) 38.1 (25.4) 19.9 (16.5) 35.2 (13.2) 24.7 (16.3) 21.9 (20.4) 27.7 (14.3) 22.1 (10.1) 16.6 (9.2) 22.1 (8.8) 21.3 (13.7) 22.4 (9.5) 15.8 (3.7) 30.0 (13.7) 26.5 (8.2)
BMI 17.4 (2.3) 17.7 (2.2) 17.2 (1.9) 17.4 (1.6) 16.9 (1.1) 17.5 (2.1) 18.0 (3.7) 15.6 (1.6) 16.3 (1.5) 18.4 (1.6) 17.9 (1.3) 16.2 (0.7) 18.6 (1.2) 18.4 (2.0)
d 1.4 1.6 2.4 2.5 2.4 1.8 0.8 1.8 1.6 2.9 2.4 - 3.8 -
Weight (kgs) 46.3 (6.7) 47.3 (6.0) 47.4 (6.1) 47.1 (5.6) 47.6 (5.1) 44.7 (6.1) 53.5 (12.1) 42.6 (4.3) 43.9 (6.4) 51.7 (6.9) 45.6 (4.2)) 44.8 (2.0) 52.3 (5.3) 49.7 (6.2)
Weekly gain (kgs) 0.3 (0.2) 0.6 (0.4) 0.3 (0.1) 0.4 (0.2) 0.5 (0.2) 0.4 (0.3) 0.5 (0.2) 0.6 (0.2) 0.3 (0.2) 0.8 (0.5) 0.4 (0.1) 0.3 (0.1) 0.6 (0.4) 0.2 (0.1)
EDE-Q Total 3.5 (1.4) 3.2 (1.9) 3.8 (1.0) 2.5 (1.9) 3.4 (1.4) 3.1 (1.7) 3.6 (1.5) 2.7 (1.1) 4.4 (1.1) 0.8 (0.3) 3.8 (0.8) 5.2 (0.8) 3.3 (1.0) 4.6
d -0.5 -0.3 -0.5 -0.9 -1.2 -0.3 -0.3 -1.1 -0.5 -1.5 -0.9 - -0.5 -
OBE N (%) 8 (40%) 4 (29%) 4 (31%) 3 (30%) 3 (25%) 3 (23%) 3 (25%) 5 (50%) 1 (20%) 1 (20%) 1 (50%) 0 2 (50%) 1
SBE N (%) 15 (71%) 5 (42%) 8 (73%) 3 (30%) 7 (64%) 3 (30%) 8 (67%) 3 (38%) 4 (100%) 1 (20%) 1 (25%) 2 (100%) 1 (25%) 1
SIV N (%) 5 (24%) 1 (8%) 2 (18%) 3 (30%) 3 (27%) 0 6 (50%) 1(12.5%) 2 (50%) 1 (20%) 2 (50%) 0 1 (25%) 0
LAX N (%) 3 (14%) 2 (17%) 2 (18%) 1 (10%) 1 (9%) 0 1 (8%) 0 2 (50%) 0 0 0 1 (25%) 0
EXERCISE N (%) 7 (33%) 4 (33%) 6 (55%) 4 (40%) 4 (40%) 3 (30%) 6 (46%) 3 (38%) 3 (75%) 0 0 1 (50%) 0 1
DASS total 74.1 (28.6) 54.7 (28.5) 77.8 (23.9) 58.0 (31.7) 68.0 (25.3) 66.2 (37.1) 62.3 (28.9) 54.0 (34.6) 88.0 (41.9) 12.8 (6.6) 63.0 (19.9) 109.0 (9.9) 39.5 (16.6) 22.0
d -0.2 -0.3 -0.2 -0.5 -0.7 -0.2 -0.7 -0.9 0.0 -0.7 -0.9 - -0.9 -
WHO QoL 3.0 (0.8) 3.8 (0.5) 2.9 (0.7) 3.7 (0.7) 3.3 (1.0) 3.1 (1.0) 2.9 (1.1) 3.2 (1.3) 2.8 (0.8) 4.6 (0.5) 3.3 (0.5) 1.5 (0.7) 3.8 (1.0) 5.0
d 0.7 0.8 0.8 1.2 1.3 0.7 0.3 1.3 -0.3 1.4 0 - 1.2 -
WHO Health 2.6 (0.9) 3.6 (0.9) 2.5 (1.0) 3.3 (0.7) 2.6 (0.9) 2.8 (1.2) 3.2 (0.7) 3.2 (1.0) 2.6 (0.5) 4.0 (0) 2.5 (1.0) 1.5 (0.7) 4.3 (1.0) 4.0
d 0.6 0.9 0.4 0.5 0.8 0.3 0.1 1.8 0.7 - 0.3 - 0.2 -
WHO Psychological 33.3 (15.8) 40.3 (15.6) 25.0 (13.2) 45.3 (16.2) 32.2 (16.0) 30.0 (22.8) 32.6 (17.1) 41.8 (24.6) 27.5 (18.3) 75.0 (12.8) 34.4 (6.3) 4.2 (0) 40.6 (17.8) 70.8
d 0.5 0.6 0.2 1.0 0.4 0.2 0.4 0.7 0.4 1.0 1.6 - 0.2 -
WHO Social 36.9 (25.6) 43.4 (22.6) 37.9 (17.2) 44.2 (23.6) 41.3 (10.9) 36.3 (16.7) 41.3 (20.0) 48.3 (28.5) 29.2 (16.0) 65.0 (34.6) 43.8 (14.2) 29.2 (29.5) 39.6 (29.2) 50.0
d 0.1 0.4 0.2 0 -0.1 0.4 0.1 0.3 -0.1 0.6 0.1 - -0.7 -
WHO Physical 55.7 (23.4) 72.9 (13.3) 58.1 (13.7) 72.2 (13.1) 59.1 (22.6) 61.9 (25.8) 62.2 (14.5) 63.1 (25.6) 51.4 (21.8) 88.6 (13.7) 58.9 (16.1) 25.0 (20.2) 87.5 (9.4) 82.1
d 0.4 1.2 0.1 0.7 0.4 0.6 0.2 0 0.6 0.5 0.4 - 0.0 -
WHO Environment 55.8 (16.7) 71.6 (9.6) 54.0 (9.8) 58.9 (16.1) 67.9 (16.5) 61.6 (15.5) 62.2 (16.4) 62.5 (20.0) 51.3 (19.3) 72.5 (23.7) 70.1 (21.0) 35.9 (24.3) 75.8 (21.3) 59.4
d 0.3 1.0 0.3 0.4 0.6 0.4 0.2 0.6 0.3 0.3 0.5 - 0.6 -
Importance to change 7.9 (2.6) 7.8 (2.6) 7.0 (2.3) 6.9 (3.0) 8.0 (1.3) 8.2 (2.0) 6.6 (3.5) 8.0 (1.7) 6.8 (0.5) 6.2 (3.8) 7.0 (2.6) 10.0 (0) 4.0 (3.8) 5.0
d -0.3 -0.3 -0.6 -0.2 -0.1 -0.6 -0.2 -0.3 - 0 -0.1 - -0.3 -
Confidence to change 5.4 (2.3) 4.8 (2.6) 4.2 (1.9) 6.2 (1.2) 6.2 (2.3) 5.5 (3.1) 4.1 (2.9) 6.8 (2.0) 4.0 (1.8) 8.8 (1.3) 4.8 (2.4) 6.0 (1.4) 5.3 (1.0) 10.0


















Table 3 Descriptive data (mean, standard deviation) at discharge and effect sizes for change pre- and post- inpatient treatment by centre: inpatients only a
(Continued)
LEE Carer 1 19.4 (14.5) 14.2 (10.9) 25.7 (11.2) 17.9 (16.6) 16.9 (12.5) 19.3 (16.6) 22.8 (14.7) 11.7 (11.8) 17.4 (15.5) 7.2(7.2) 15.8 (10.9) 31.5 (20.5) 15.6(7.4) 11.0
d 0.4 0.1 0.1 0.3 0.4 -0.1 0.1 -0.4 0.0 -0.8 0.3 - -0.4 -
PCS mother 2.6 (1.0) 2.0 (1.0) 2.6 (0.8) 2.5 (1.3) 2.1 (1.0) 2.6 (1.2) 2.5 (0.8) 1.9 (0.8) 1.6 (0.8) 2.5 (0.7) 1.9 (0.8) 4.3 (0.9) 1.9 (0.4) 2.0
d 0.1 0.1 0.0 0.2 0.3 0.0 0 0.0 0.0 0.5 0.5 - 0 -
PCS father 2.3 (0.7) 1.9 (0.9) 2.7 (1.0) 2.2 (1.4) 1.8 (0.5) 1.9 (0.9) 2.0 (0.7) 1.8 (1.0) 1.8 (1.3) 2.2 (1.3) 1.9 (0.3) 2.4 (0.5) 2.1 (0.1) 1.4
d 0.1 0.1 0.2 -0.1 0.2 0.1 0.1 0.1 0.0 0 0.3 - 0.6 -
ª Not every participant answered every question; * Adolescent centre; N = sample number included; d = Cohen’s d effect sizes for paired t-tests. Effect sizes are therefore completed for complete admission-discharge
pairs. BMI: Body Mass Index; EDE-Q Eating Disorder Examination Questionnaire; OBE: Objective binge episodes with loss of control; LOC: eating with loss of control other than binge; SIV: Self induced vomiting; LAX:
Laxative use; EXER: Excessive exercise; Note: diuretic use was not endorsed by anyone. DASS: Depression, Anxiety and Stress Scale; WHO: World Health Organisation; QoL: Overall quality of life (1-5 high); HEALTH: Over-
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Inpatient treatment was successful for BMI (huge effect
size). However, there was a large range in individual dis-
charge BMI (11.9 – 24.4). The average rate of weekly
weight gain over the duration of the admission varied
widely between individuals (0.2 – 1.7 kg per week.)
Effect sizes for change in BMI were large for all sites but
there was a two-fold difference in the size of the effect
between some sites. The rate of weight gain was lower
than the minimum recommendation by NICE (0.5 kgs)
in eight centres (seven adult).
The majority of adult inpatients remained in the AN
BMI range at discharge from hospital (58%). Twenty
(14%) of these had a discharge BMI of ≤ 15 and a further
62 (44%) had a BMI ≤ 17.5. Only 22 percent (N = 31) of
patients had a BMI >19 at discharge.
Eating psychopathology
Scores on EDEQ improved significantly with moderate
sized effects. The only ED behaviour for which there was a
significant reduction in the number of patients endorsing
the behaviour was excessive exercise. There was a two-three
fold difference in the size of effect between some centres.
Mood, quality of life and motivation to change
Mean discharge scores for depression and anxiety remained
in the severe range and ‘stress’ scores fell within the upper
moderate range. There was no change in social wellbeing.
Ratings on ‘importance to change’ significantly reduced
over the treatment period and there were no changes in
‘confidence to change’.
There was a three-fold difference in the size of effects
for mood and quality of life outcomes across centres.
There was an increase in ‘importance to change’ in only
two centres and an increase in ‘confidence to change’ in
five centres.
Family relationship
Overall, there were no changes in perceived expressed
emotion or perceived psychological control for any group.
Adolescent inpatients
Length of stay
One adolescent patient remained in hospital at the time
of data analysis. There was a tendency for adolescents to
have a longer admission than adults but there was wide
variation (15.9 – 56.0 weeks).
Response to treatment
BMI
The overall increase in BMI in adolescents was double
that of the adult sample. The rate of weekly weight gain
was slightly more than adults.Eating psychopathology
There were small reductions in ED specific psychopath-
ology and, like adults, the only behavioural measure to
show change was excessive exercise.
Mood, quality of life and motivation to change
Effect sizes for improvements in mood were larger for ado-
lescents than for adults and there was improvement in all
WHO Quality of Life subscales. ‘Importance to change’ re-
duced but, unlike adults, ‘confidence to change’ increased
over the treatment period.
Inpatient vs Day patient
Length of stay
The length of stay was shorter for day patients than in-
patients (U = 786.5, p = .026).
Response to treatment
Overall, specific and general symptoms improved with
day patient care but the effects were smaller than for
inpatients.
BMI
There was a moderate increase in BMI but 40% of day
patients remained in the AN weight range at discharge.
The weekly rate of weight gain was modest with large
individual variation (0.1kg; range: -0.2 – 1.2).
Eating psychopathology
Change in ED specific psychopathology was significant
(large effects) but 40% remained above the clinically sig-
nificant threshold. There was no change in number of
patients engaging in ED behaviours.
Mood, quality of life and motivation to change
There were small to medium improvements in mood
and quality of life. Both ‘importance to change’ and ‘con-
fidence to change’ reduced over the treatment period.
Predictors of response to treatment
Preliminary analysis
A skewed distribution was found for expressed emotion
(LEE). Square root transformations were applied to this
score to better approximate a normal distribution for
the analyses involving this variable. There was no indica-
tion of multicollinearity as tolerance statistics were
above .20, and variance inflation factors were below 4.
Table 2 shows descriptive statistics (mean and SD) of all
study variables.
Correlation analysis
Table 4 reports correlations between the study variables.
We found that ED symptoms at discharge were
Table 4 Descriptive statistics and correlations among the study variables (n = 107)
Mean SD 1 2 3 4 5 6 7 8
1. BMI on admission 14.25 2.38 -
2. ED symptoms admission (EDEQ) 4.16 1.28 .100 -
3. Distress (DASS) 74.50 28.35 .042 .5542** -
4. Confidence in ability to change 5.52 2.68 -.098 -.446** -.531** -
5. Expressed Emotion (LEE) 19.92 16.43 .020 .164 .376** -.254** -
6. Social Quality of Life (WHO QoL) 10.34 3.40 -.084 -.171 -.317** .310** -.410** -
7. Mothers' Psychological Control 2.33 1.04 .075 .143 .284** -.130 .635** -.250** -
8. Fathers' Psychological Control 2.16 .90 .136 .097 .123 -.269** .384** -.174 .455** -
9. ED symptoms at discharge (EDEQ) 3.36 1.44 .096 .536** .575** -.512** .256** -.097 .128 -.008
BMI = Body mass Index in admission; EDEQ: Eating Disorder Examination Questionnaire; DASS: Depression, Anxiety and Stress Scale; LEE: Levels of Expressed
Emotion; WHO: World Health Organization; QoL: Quality of Life;
* p < .05; ** p < .01.
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http://www.biomedcentral.com/1471-244X/13/287positively correlated with ED symptoms on admission,
patients’ mood and expressed emotion, and negatively
related to patients’ confidence in ability to change.
Regression analysis
Table 5 summarises the results of the hierarchical regres-
sion analyses in which four individual factors and four
interpersonal factors were entered consecutively to explain
ED symptoms at discharge. The cumulative variance
accounted for by the entire model, as well as the incremen-
tal for each block are presented. Overall, individual vari-
ables accounted for a significant amount of variance (42%,
p < .001) in predicting ED symptoms at discharge. In this
equation, ED symptoms on admission (β = .264, p = < .01),
patients distress (β = .311, p = < .01) and confidence in
ability to change (β = −.227, p = < .05) made significant
contributions to explain ED symptoms at discharge. InTable 5 Regression analysis on eating psychopathology at di
B SE β
DV: EDEQ at discharge
Step 1
BMI admission .021 .045
Eating disorder symptoms in admission .297 .102
Distress .016 .005
Confidence in ability to change -.122 .048
Step 2
BMI admission .041 .044
Eating disorder symptoms in admission .297 .099
Distress .014 .005
Confidence in ability to change -.159 .049
Expressed Emotion .171 .085
Social Quality of Life .076 .035
Mothers’ Psychological Control -.046 .137
Fathers’ Psychological Control -.303 .136the second equation, ED symptoms on admission (β = .264,
p = < .01), patients distress (β = .285, p = < .01) and confi-
dence in the ability to change (β = −.295, p = < .01)
remained as predictors of ED symptoms at discharge, and
the subsequent entry of interpersonal variables accounted
for significant incremental variance over and above individ-
ual factors in predicting 6% (p < .05) additional variance.
This can be largely attributed to the significant contribution
of expressed emotion (β = .205, p <.05), social quality of life
(β = .178, p < .05), and perceived psychological control in
fathers (β = −.189, p < .05).
Discussion
This study represents a unique collaboration of major
UK ED treatment centres and describes a cross-section
of severely ill patients with AN at admission and dis-
charge from specialist hospital treatment.scharge
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The majority of patients had a severe and enduring form
of illness and had failed to respond to earlier intensive
treatment. They had high levels of functional impair-
ment and most were living with their family of origin
prior to their admission. Day patients had a higher
weight at admission and less severe historical illness
characteristics (lowest BMI, previous admissions) than
inpatients. Adolescents had a higher BMI and less pro-
tracted illness than adults.
Change in symptoms at discharge - inpatients
The change in clinical symptoms during the period of
treatment was large for weight gain but modest for most
other symptoms. The majority of patients were discharged
when their BMI remained within the AN diagnostic
weight range (≤ 17.5) and two thirds of the sample
remained within the clinical range of general and specific
psychopathology. Overall, the proportion of people en-
gaging in compensatory behaviours did not show great
change at discharge. Perceptions of quality of life and
health improved but all domains remained low upon dis-
charge relative to population norms [36]. However, this
might be expected since patients need to reconnect so-
cially and/or professionally having recently been dis-
charged. Similarly, since psychotherapy sometimes needs a
certain physical health to work in depth on psychological
symptoms, it is possible that the lack of improvement in
ED and mood symptoms is associated with the discharge
weight of the group remaining within the pathological ED
criteria. Patients’ weight and symptom status at discharge
is of concern given previous reports that low weight pre-
dicts relapse [23,37,38].
Change in symptoms at discharge - service level day
patients/adolescents
BMI increase was smaller in day patients than in inpa-
tients and at end of treatment, 40% of day patients
remained within an anorexic BMI range. Day patients
remained symptomatic at discharge and quality of life
was poor. The change in BMI in the adolescent inpatient
group was twice that attained for adults; this was associ-
ated with an elevated rate of weight gain and a small in-
crease in the length of stay. There was also a larger
improvement in mood and quality of life, and ‘confi-
dence to change’ also increased over the treatment
period which was not seen in the adults.
Predictors of ED symptoms at discharge
Clinical and social parameters predicted symptom
change and some of these have the potential to be modi-
fied by change in clinical policy or practice. The level of
patient’s mood psychopathology, confidence, social qual-
ity of life, perceived level of father’s control and carerexpressed emotion predicted ED symptoms at discharge.
The level of confidence has previously been found to
predict the response to inpatient care [39] and has been
found to have implications for post-inpatient outcomes
[23]. Social function and family response to the illness
(expressed emotion, father’s psychological control) pre-
dicted outcome and this supports the interpersonal main-
tenance model of EDs [24,25]. Carer expressed emotion has
previously been found to contribute to the outcome of ado-
lescent AN [40-42] and adults with bulimia nervosa (BN)
admitted for inpatient care [43]. It is possible that if
inpatient treatment targeted these psychosocial factors, and
were inclusive of families, outcomes would be improved.
Clinical implications
Inpatient care is able to produce an improvement in
physical health but psychological and social health re-
mains impaired. There are several ways in which treat-
ment could be focused on those factors that might
modify the response to inpatient care. Strategies to im-
prove confidence to change such as motivational inter-
viewing may be of value to improve outcome [44-46].
Targeting interpersonal relationships with interventions
that reduce expressed emotion [47,48] may be of benefit.
Strategies included in the recovery approach may reduce
the social isolation [24,49] and loneliness [50] that con-
tribute to the poor social quality of life.
Limitations
There are limitations of this study. Primarily, the data do
not represent all patients admitted but only the group who
consented to be involved in a study that involves their
carers. It is possible that the sample is therefore biased to-
wards including carers who were more actively involved in
their loved one’s care. The samples recruited from each site
or type of service were small, limiting the power to exam-
ine service level predictors. The percentage of adolescent
inpatients and day patients is also small in comparison to
the adult inpatient sample size which limits the overall
outcome interpretation. All psychological outcomes were
measured using self report questionnaires. Clinical
interviews would improve reliability of findings. There
were missing data for some of the predictor variables of
interest, reducing data available for the regression analysis.
However, it is a strength of the study that discharge data
were collected from patients regardless of whether they
completed the full inpatient/day patient programme, so it
is representative of those who leave hospital treatment for
AN. Data on whether patients took their own discharge,
whether clinicians suggested an early discharge or whether
they completed the programme were not assessed in this
study since the information was not available for all sites
and the definitions of each of these premature terminations
of treatment are variable. It would be of interest to
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in future studies. Similarly, it would be interesting to exam-
ine outcomes based on different therapeutic approaches
within and between sites. Lastly, we did not differentiate
between patients who were admitted on a voluntary basis
and those detained under the Mental Health Act. Despite
these limitations, these data are a realistic reflection of
current NHS practice of inpatient care in the UK and this
paper presents a platform for future research in the area.
Conclusion
Overall, the response to inpatient treatment was modest
particularly in adults with a severe enduring form of ill-
ness. Adolescents had a better response. Although in-
patient treatment produces an improvement in physical
health, there was less improvement in other ED and
mood symptoms. As predicted by the interpersonal
maintenance model, carer behaviour may influence the
response to inpatient care, as may improved social func-
tioning and confidence to change. Interventions targeting
these factors might improve the treatment response.
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